Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...

Graphite One Inc. (TSXV: GPH) (OTCQX: GPHOF) ("Graphite One", or the "Company"), is pleased to announce that as part of its plan to build a complete U.S. supply chain for advanced graphite materials, ...

T.J. Rogers, founder of former Cypress Semiconductor is forging global strategic alliances and hunting acquisition targets to ...

Mavenir Open vRAN and O-RAN compliant small cells central to success of Three UK's Glasgow City Centre roll-out - boosting coverage and capacity across a high-demand, dense urban environment Landmark ...

EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment ...

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...

Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using ...

Over 500 million people worldwide suffer from diabetes-a disease that contributes to major complications such as stroke, ...